Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity

Hu-lai WEI; Xiao-jian YAO; Yu-ning LI; Pei WANG; Huai-shun ZHAO; De-cheng BAI; Xiao PENG; Lan-fang MA.
Chinese Journal of Hematology ; (12): 28-31, 2003.
Artículo en Zh | WPRIM | ID: wpr-261363

Documentos relacionados

  1. [Resistance reversal effect of a novel taxane compound NPB304 and its collaboration with verapamil].
  2. Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition.
  3. Overexpression of tensin homolog deleted on chromosome ten (PTEN) by ciglitazone sensitizes doxorubicin-resistance leukemia cancer cells to treatment.
  4. Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity.
  5. Rewired metabolism in drug-resistant leukemia cells: a metabolic switch hallmarked by reduced dependence on exogenous glutamine.
  6. SLC25A40 Facilitates Anticancer Drug Resistance in Human Leukemia K562 Cells.
  7. Synthesis and Anticancer Activity of A-Ring-Modified Derivatives of Dihydrobetulin.
  8. Nanoenabled Intracellular Calcium Bursting for Safe and Efficient Reversal of Drug Resistance in Tumor Cells.
  9. [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity].
  10. A new anthracycline with potent anti-leukemic activity overcomes P-glycoprotein multidrug resistance.